{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:57:11Z","timestamp":1791943031114,"version":"4.3.4"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,15]]},"DOI":"10.2146\/ajhp170279","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T10:31:06Z","timestamp":1523010666000},"page":"524-531","source":"Crossref","is-referenced-by-count":82,"title":["Evaluating off-label uses of acetazolamide"],"prefix":"10.1093","volume":"75","author":[{"given":"Megan A.","family":"Van Berkel","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Erlanger Health System, Chattanooga, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Elefritz","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Wexner Medical Center, Ohio State University, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041105245489500_b1-0750524","volume-title":"Diamox (acetazolamide for injection, USP) package insert","year":"2013"},{"key":"key\n\t\t\t\t2019041105245489500_b2-0750524","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1152\/japplphysiol.01572.2005","article-title":"Mechanism of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness","volume":"102","author":"Leaf","year":"2007","journal-title":"J Appl Physiol"},{"key":"key\n\t\t\t\t2019041105245489500_b3-0750524","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00003246-199907000-00004","article-title":"Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial","volume":"27","author":"Mazur","year":"1999","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t2019041105245489500_b4-0750524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc11323","article-title":"Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit?","volume":"16","author":"Heming","year":"2012","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t2019041105245489500_b5-0750524","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0884533608314534","article-title":"Diagnosis and treatment of simple acid-base disorders","volume":"23","author":"Ayers","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"key\n\t\t\t\t2019041105245489500_b6-0750524","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jama.2016.0019","article-title":"Effect of acetazolamide vs. placebo on duration of mechanical ventilation among patients with chronic obstructive pulmonary disease: a randomized clinical trial","volume":"315","author":"Faisy","year":"2016","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041105245489500_b7-0750524","first-page":"354","article-title":"Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit","volume":"46","author":"Gursel","year":"2001","journal-title":"Respir Care"},{"key":"key\n\t\t\t\t2019041105245489500_b8-0750524","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/cc3970","article-title":"Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients","volume":"10","author":"Moviat","year":"2006","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t2019041105245489500_b9-0750524","first-page":"455","article-title":"Acetazolamide in the treatment of metabolic alkalosis in critically ill patients","volume":"20","author":"Marik","year":"1991","journal-title":"Heart Lung"},{"key":"key\n\t\t\t\t2019041105245489500_b10-0750524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc10448","article-title":"Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients","volume":"15","author":"Heming","year":"2011","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t2019041105245489500_b11-0750524","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/PCC.0000000000000313","article-title":"Acetazolamide therapy for metabolic alkalosis in critically ill pediatric patients","volume":"16","author":"Bar","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"key\n\t\t\t\t2019041105245489500_b12-0750524","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1060028013500468","article-title":"Acetazolamide in critically ill neonates and children with metabolic alkalosis","volume":"47","author":"Andrews","year":"2013","journal-title":"Ann Pharmaother"},{"key":"key\n\t\t\t\t2019041105245489500_b13-0750524","first-page":"CD002881","article-title":"Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease","volume":"1","author":"Greenston","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041105245489500_b14-0750524","first-page":"110","article-title":"Acetazolamide in hypercapnic chronic obstructive lung disease\u2014a renaissance?","volume":"113","author":"Hacki","year":"1983","journal-title":"Schweiz Med Wochenschr"},{"key":"key\n\t\t\t\t2019041105245489500_b15-0750524","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/arrd.1983.127.4.405","article-title":"Relative effectiveness of acetazolamide versus medroxyprogesterone acetate in correction of chronic carbon dioxide retention","volume":"127","author":"Skatrud","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t2019041105245489500_b16-0750524","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1183\/09031936.94.07050850","article-title":"Effects of chloromadione acetate and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease","volume":"7","author":"Vos","year":"1994","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t2019041105245489500_b17-0750524","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1378\/chest.123.5.1450","article-title":"Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD","volume":"123","author":"Wagenaar","year":"2003","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041105245489500_b18-0750524","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00134-010-1795-7","article-title":"Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation","volume":"36","author":"Faisy","year":"2010","journal-title":"Int Care Med"},{"key":"key\n\t\t\t\t2019041105245489500_b19-0750524","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/crj.12025","article-title":"Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis","volume":"7","author":"Gulsvik","year":"2013","journal-title":"Clin Respir J"},{"key":"key\n\t\t\t\t2019041105245489500_b20-0750524","doi-asserted-by":"crossref","first-page":"e86313","DOI":"10.1371\/journal.pone.0086313","article-title":"Population pharmacodynamic modeling and simulation of the respiratory effect of acetazolamide in decompensated COPD patients","volume":"9","author":"Heming","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041105245489500_b21-0750524","first-page":"37","article-title":"Effect of acetazolamide on post-NIV metabolic alkalosis in acute exacerbated COPD patients","volume":"20","author":"Fontana","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key\n\t\t\t\t2019041105245489500_b22-0750524","article-title":"Global strategy for the diagnosis, management and prevention of COPD (GOLD) 2017","author":"Global Initiative for Chronic Obstructive Lung Disease"},{"key":"key\n\t\t\t\t2019041105245489500_b23-0750524","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3565(25)29822-6","article-title":"The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity","volume":"189","author":"McCarthy","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041105245489500_b24-0750524","first-page":"467","article-title":"Analysing the effect of early acetazolamide administration on patients with a high risk of permanent cerebrospinal fluid leakage","volume":"51","author":"Abrishamkar","year":"2013","journal-title":"Acta Med Iran"},{"key":"key\n\t\t\t\t2019041105245489500_b25-0750524","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1152\/japplphysiol.01393.2010","article-title":"Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia","volume":"110","author":"Subudhi","year":"2011","journal-title":"J Appl Physiol"},{"key":"key\n\t\t\t\t2019041105245489500_b26-0750524","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1161\/01.STR.26.12.2358","article-title":"Effect of acetazolamide on regional cerebral oxygen saturation and regional cerebral blood flow","volume":"26","author":"Kaminogo","year":"1995","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019041105245489500_b27-0750524","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12987-015-0004-z","article-title":"MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalus","volume":"9","author":"Ivkovic","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"key\n\t\t\t\t2019041105245489500_b28-0750524","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pnpbp.2005.01.006","article-title":"Influences of caffeine, acetazolamide and cognitive stimulation on cerebral blood flow velocities","volume":"29","author":"Haase","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t2019041105245489500_b29-0750524","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/hs0901.095692","article-title":"Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it?","volume":"32","author":"Kuroda","year":"2001","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019041105245489500_b30-0750524","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3174\/ajnr.A1538","article-title":"The acetazolamide challenge: techniques and applications in the evaluation of chronic cerebral ischemia","volume":"30","author":"Vagal","year":"2009","journal-title":"Am J Neuroradiol"},{"key":"key\n\t\t\t\t2019041105245489500_b31-0750524","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ncl.2010.03.003","article-title":"Idiopathic intracranial hypertension","volume":"28","author":"Wall","year":"2010","journal-title":"Neurol Clin"},{"key":"key\n\t\t\t\t2019041105245489500_b32-0750524","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/WCO.0b013e328341f94a","article-title":"The syndrome of pseudotumor cerebri and idiopathic intracranial hypertension","volume":"24","author":"Fraser","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"key\n\t\t\t\t2019041105245489500_b33-0750524","first-page":"CD003434","article-title":"Interventions for idiopathic intracranial hypertension","volume":"8","author":"Piper","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041105245489500_b34-0750524","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s00415-010-5861-4","article-title":"A randomised controlled trial of treatment for idiopathic intracranial hypertension","volume":"258","author":"Ball","year":"2011","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t2019041105245489500_b35-0750524","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0404.2007.00905.x","article-title":"Treatment of idiopathic intracranial hyperension: topiramate vs acetazolamide, an open-label study","volume":"116","author":"Celebisoy","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t2019041105245489500_b36-0750524","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the Idiopathic Intracranial Hypertension Treatment Trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041105245489500_b37-0750524","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.otc.2011.06.007","article-title":"Traumatic cerebrospinal fluid leaks","volume":"44","author":"Prosser","year":"2011","journal-title":"Otolaryngol Clin North Am"},{"key":"key\n\t\t\t\t2019041105245489500_b38-0750524","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10143-005-0396-3","article-title":"Cerebrospinal fluid leakage complicating skull base fractures: analysis of 81 cases","volume":"29","author":"Yilmazlar","year":"2006","journal-title":"Neurosurg Rev"},{"key":"key\n\t\t\t\t2019041105245489500_b39-0750524","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/alr.21188","article-title":"Acetazolamide for high intracranial pressure cerebrospinal fluid leaks","volume":"3","author":"Chaaban","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"key\n\t\t\t\t2019041105245489500_b40-0750524","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/icvts\/ivt384","article-title":"Novel application of acetazolamide to reduce cerebrospinal fluid production in patients undergoing thoracoabdominal aortic surgery","volume":"18","author":"Jafarzadeh","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"key\n\t\t\t\t2019041105245489500_b41-0750524","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3171\/2015.8.PEDS15393","article-title":"Randomized clinical trial of acetazolamide administration and\/or prone positioning in mitigating wound complications following untethering surgeries","volume":"17","author":"Shahjouei","year":"2016","journal-title":"J Neurosurg Pediatr"},{"key":"key\n\t\t\t\t2019041105245489500_b42-0750524","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"Newton","year":"2002","journal-title":"Clin Infec Dis"},{"key":"key\n\t\t\t\t2019041105245489500_b43-0750524","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1258\/0049475053001967","article-title":"Feasibility study of serial lumbar puncture and acetazolamide combination in the management of elevated cerebrospinal fluid pressure in AIDS patients with cryptococcal meningitis in Uganda","volume":"35","author":"Orem","year":"2005","journal-title":"Trop Doct"},{"key":"key\n\t\t\t\t2019041105245489500_b44-0750524","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1086\/367646","article-title":"Acetazolamide and intracranial pressure","volume":"36","author":"Patel","year":"2003","journal-title":"Clin Infec Dis"},{"key":"key\n\t\t\t\t2019041105245489500_b45-0750524","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.urology.2008.04.003","article-title":"Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate","volume":"72","author":"Sterrett","year":"2008","journal-title":"Urology"},{"key":"key\n\t\t\t\t2019041105245489500_b46-0750524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/CLT-120028740","article-title":"Position paper on urine alkalinization","volume":"42","author":"Proudfoot","year":"2004","journal-title":"J Toxicol Clin Toxicol"},{"key":"key\n\t\t\t\t2019041105245489500_b47-0750524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)30302-2","article-title":"CO2 retention as a basis for increased toxicity of salicylate with acetazolamide: avoidance of increased toxicity with benzolamide","volume":"195","author":"Liddell","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041105245489500_b48-0750524","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00689708","article-title":"Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate","volume":"28","author":"Shamash","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"key\n\t\t\t\t2019041105245489500_b49-0750524","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0277-5379(88)90320-3","article-title":"The use of Diamox in the sequential methotrexate-5-fluorouracil therapy of advanced gastrointestinal cancer","volume":"24","author":"Abe","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"key\n\t\t\t\t2019041105245489500_b50-0750524","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-5347(17)67096-4","article-title":"Acetazolamide induced renal calculi","volume":"114","author":"Rubenstein","year":"1975","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041105245489500_b51-0750524","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11255-008-9520-y","article-title":"A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial","volume":"41","author":"Pakfetrat","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"key\n\t\t\t\t2019041105245489500_b52-0750524","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00246-005-1132-z","article-title":"Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug","volume":"27","author":"Assadi","year":"2006","journal-title":"Pediatr Cardiol"},{"key":"key\n\t\t\t\t2019041105245489500_b53-0750524","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.115.225177","article-title":"Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury","volume":"355","author":"Bejaoui","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041105245489500_b54-0750524","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.ta.0000224136.77198.7e","article-title":"Novel use of acetazolamide in the treatment of rhabdomyolysis-induced myoglobinuric renal failure","volume":"61","author":"Davidov","year":"2006","journal-title":"J Trauma"},{"key":"key\n\t\t\t\t2019041105245489500_b55-0750524","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMc1609483","article-title":"Acetazolamide in lithium-induced nephrogenic diabetes insipidus","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041105245489500_b56-0750524","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.msard.2015.06.015","article-title":"Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations","volume":"4","author":"Schroder","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"key\n\t\t\t\t2019041105245489500_b57-0750524","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajo.2004.02.019","article-title":"Presumed \u201csulfa allergy\u201d in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality?","volume":"138","author":"Lee","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key\n\t\t\t\t2019041105245489500_b58-0750524","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2796.1990.tb00290.x","article-title":"Acetazolamide-associated aplastic anaemia","volume":"228","author":"Keisu","year":"1990","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041105245489500_b59-0750524","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom","year":"2003","journal-title":"N Engl J Med"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/75\/8\/524\/28347372\/ajhp0524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T13:32:01Z","timestamp":1751549521000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/75\/8\/524\/5102351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,15]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,4,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp170279","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4,15]]},"published":{"date-parts":[[2018,4,15]]}}}